CHICAGO–GE HealthCare (Nasdaq: GEHC) has introduced Allia Celeo, a new ceiling-mounted medical imaging system that uses artificial intelligence to support cardiovascular and interventional radiology procedures while improving workflow efficiency in hospital operating environments.
The system was unveiled at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. It is designed to help physicians perform complex image-guided procedures by combining advanced imaging capabilities, automated positioning and AI-assisted adjustments to image quality and radiation exposure.
Allia Celeo is part of GE HealthCare’s Allia platform, which provides imaging technology for interventional suites where physicians perform minimally invasive cardiovascular, radiology and other image-guided procedures.
The new system features an extra-wide-bore C-arm mounted on a ceiling gantry, allowing imaging equipment to move around patients while providing additional space for physicians, nurses and other medical personnel.
The design is intended to accommodate patients of different sizes, including those with a high body mass index, while allowing clinicians to position the imaging equipment at steep angles required for certain procedures.
“Every interventional suite has its own rhythm, and care teams need a system that adapts to the way they work rather than the other way around,” said Jyoti Gera, Chief Executive Officer, CardioVascular and Interventional Solutions (CVIS), Advanced Imaging Solutions (AIS), GE HealthCare. “Allia Celeo extends our Allia platform with a ceiling-mounted system built for that kind of flexibility, giving hospitals more choice in how they configure their interventional suites while supporting our vision for more personalized, precise care.”
The system incorporates a slim, symmetrical ceiling-mounted structure with integrated cabling to reduce obstructions around the patient table.
Its design includes a narrow C-arm and detector lift intended to improve visibility and communication among medical personnel during procedures.
The imaging equipment can move rapidly along ceiling-mounted tracks and provide extended coverage of the patient, supporting imaging from head to toe.
An integrated feature called InnovaBreeze automatically coordinates movement of the patient table and imaging equipment to capture the anatomy of the lower limbs in a single imaging sequence.
Allia Celeo also incorporates a real-time digital twin, a virtual representation of the equipment that helps clinicians preview and optimize positioning before moving the imaging system.
Physicians and other clinical staff can adjust the gantry and patient table from multiple locations within the procedure room. The system also provides customizable controls and screen layouts to accommodate different clinical workflows.
A central feature of Allia Celeo is its AI-enabled imaging technology, which is designed to automatically adjust imaging parameters to maintain image quality while limiting radiation exposure.
The system supports both two-dimensional and three-dimensional imaging and includes advanced rendering tools that allow physicians to select preferred cardiac imaging views with a single command.
“We designed Allia Celeo around a simple idea: a procedure should move at the pace of the care team, not the equipment,” said Kat Davis, General Manager, Interventional Solutions, CVIS, AIS, GE HealthCare. “From a digital twin that previews gantry positioning to an image chain that manages dose in the background, each element is intended to reduce the small interruptions that add up over a day in the interventional suite, so clinicians can stay focused on their patients.”
The platform is designed to integrate with several existing GE HealthCare technologies used in cardiovascular procedures.
These include StentViz and 3DStenti, which support visualization of coronary stents, and Valve ASSIST 2, which assists physicians in planning structural heart procedures.
The system is also compatible with GE HealthCare’s Mac-Lab hemodynamic monitoring platform, which incorporates fractional flow reserve and diastolic pressure ratio measurements used to assess coronary artery disease.
For interventional radiology and oncology procedures, Allia Celeo supports applications such as Embo ASSIST AI, Vessel ASSIST and Needle ASSIST, which provide tools for embolization planning, three-dimensional vascular imaging and needle guidance.
The system can also integrate with GE HealthCare’s Vscan Air handheld ultrasound device and compatible third-party intravascular imaging and physiological measurement systems.
Beyond imaging capabilities, Allia Celeo is designed to work with OnWatch Predict, GE HealthCare’s remote monitoring and predictive maintenance technology.
OnWatch Predict uses continuous equipment monitoring and deep learning-based analytics to identify potential technical problems before they result in unexpected downtime.
The technology is intended to help hospitals schedule maintenance proactively, reduce interruptions to clinical services and maintain more predictable patient appointment schedules.
Allia Celeo is the second new imaging system introduced within the Allia family in less than a year.
GE HealthCare unveiled the floor-mounted Allia Moveo system in 2025 and commercially launched it earlier in 2026.
The company has also introduced an upgrade program designed to bring newer Allia platform capabilities to existing customers.
With the addition of Allia Celeo, GE HealthCare is expanding its portfolio of AI-enabled interventional imaging technologies to accommodate different hospital room configurations, clinical requirements and procedural workflows.
